Lyssikatos Joseph P (CIK 0001967150)

Latest company ownership

ELVN - Enliven Therapeutics, Inc.
Role: CHIEF SCIENTIFIC OFFICER
Shares held
902,688
Last filed at
Nov 21, 2025
Confidence Score
39.8
2025Q4
Confidence Score History
2023Q3 2025Q4

Recent buy/sell transactions

Exec date Filing date Company Role Signal Confidence Shares % of shares Under plan? Amount (USD)
Dec 19, 2025 Dec 23, 2025 Enliven Therapeutics, Inc. CHIEF SCIENTIFIC OFFICER Sell 48.8 -5,000 -0.55% ✓ $84.2K
Nov 19, 2025 Nov 21, 2025 Enliven Therapeutics, Inc. CHIEF SCIENTIFIC OFFICER Sell 42.5 -12,500 -1.37% ✓ $279.2K
Oct 20, 2025 Oct 22, 2025 Enliven Therapeutics, Inc. CHIEF SCIENTIFIC OFFICER Sell 42.5 -12,500 -1.35% ✓ $276K
Sep 26, 2025 Sep 30, 2025 Enliven Therapeutics, Inc. CHIEF SCIENTIFIC OFFICER Sell 48.8 -4,000 -0.43% ✓ $81K
Sep 23, 2025 Sep 25, 2025 Enliven Therapeutics, Inc. CHIEF SCIENTIFIC OFFICER Sell 53.8 -1,500 -0.16% ✓ $30K
Sep 19, 2025 Sep 23, 2025 Enliven Therapeutics, Inc. CHIEF SCIENTIFIC OFFICER Sell 47.5 -7,000 -0.74% ✓ $135.7K
Aug 19, 2025 Aug 21, 2025 Enliven Therapeutics, Inc. CHIEF SCIENTIFIC OFFICER Sell 45.0 -12,500 -1.31% ✓ $248.2K
Jul 21, 2025 Jul 23, 2025 Enliven Therapeutics, Inc. CHIEF SCIENTIFIC OFFICER Sell 42.5 -12,500 -1.30% ✓ $278.6K
Jun 20, 2025 Jun 24, 2025 Enliven Therapeutics, Inc. CHIEF SCIENTIFIC OFFICER Sell 42.5 -12,500 -1.28% ✓ $267.5K
Jun 3, 2025 Jun 5, 2025 Enliven Therapeutics, Inc. CHIEF SCIENTIFIC OFFICER Sell 47.5 -7,500 -0.76% ✓ $150.2K
May 19, 2025 May 21, 2025 Enliven Therapeutics, Inc. CHIEF SCIENTIFIC OFFICER Sell 47.5 -5,000 -0.50% ✓ $81.5K
May 1, 2025 May 5, 2025 Enliven Therapeutics, Inc. CHIEF SCIENTIFIC OFFICER Sell 47.5 -7,500 -0.75% ✓ $150.4K
Apr 21, 2025 Apr 23, 2025 Enliven Therapeutics, Inc. CHIEF SCIENTIFIC OFFICER Sell 48.8 -5,000 -0.50% ✓ $80.4K
Mar 19, 2025 Mar 21, 2025 Enliven Therapeutics, Inc. CHIEF SCIENTIFIC OFFICER Sell 42.5 -12,500 -1.23% ✓ $257.6K
Oct 18, 2024 Oct 22, 2024 Enliven Therapeutics, Inc. CHIEF SCIENTIFIC OFFICER Sell 55.0 -847 -0.08% ✓ $25.4K
Oct 8, 2024 Oct 10, 2024 Enliven Therapeutics, Inc. CHIEF SCIENTIFIC OFFICER Sell 32.5 -51,145 -4.79% ✓ $1.4M
Oct 4, 2024 Oct 8, 2024 Enliven Therapeutics, Inc. CHIEF SCIENTIFIC OFFICER Sell 45.0 -10,229 -0.95% ✓ $281.7K
Oct 1, 2024 Oct 3, 2024 Enliven Therapeutics, Inc. CHIEF SCIENTIFIC OFFICER Sell 57.5 -527 -0.05% ✓ $14.5K
Aug 29, 2024 Sep 3, 2024 Enliven Therapeutics, Inc. CHIEF SCIENTIFIC OFFICER Sell 42.5 -12,000 -1.10% ✓ $269.8K
Jul 31, 2024 Aug 2, 2024 Enliven Therapeutics, Inc. CHIEF SCIENTIFIC OFFICER Sell 48.8 -3,099 -0.28% ✓ $85.4K
Jul 29, 2024 Jul 31, 2024 Enliven Therapeutics, Inc. CHIEF SCIENTIFIC OFFICER Sell 42.5 -12,000 -1.09% ✓ $320.4K
Jul 1, 2024 Jul 3, 2024 Enliven Therapeutics, Inc. CHIEF SCIENTIFIC OFFICER Sell 42.5 -12,000 -1.07% ✓ $274.7K
May 29, 2024 May 31, 2024 Enliven Therapeutics, Inc. CHIEF SCIENTIFIC OFFICER Sell 42.5 -12,000 -1.06% ✓ $260.8K
Apr 29, 2024 May 1, 2024 Enliven Therapeutics, Inc. CHIEF SCIENTIFIC OFFICER Sell 45.0 -12,000 -1.06% ✓ $215K
Apr 11, 2024 Apr 15, 2024 Enliven Therapeutics, Inc. CHIEF SCIENTIFIC OFFICER Sell 38.8 -30,000 -2.62% ✓ $751.3K
Apr 1, 2024 Apr 3, 2024 Enliven Therapeutics, Inc. CHIEF SCIENTIFIC OFFICER Sell 45.0 -12,000 -1.06% ✓ $223.1K
Feb 29, 2024 Mar 4, 2024 Enliven Therapeutics, Inc. CHIEF SCIENTIFIC OFFICER Sell 45.0 -12,000 -1.06% ✓ $197K
Jan 29, 2024 Jan 31, 2024 Enliven Therapeutics, Inc. CHIEF SCIENTIFIC OFFICER Sell 45.0 -12,000 -1.06% ✓ $190.3K
Dec 29, 2023 Jan 3, 2024 Enliven Therapeutics, Inc. Chief Scientific Officer Sell 45.0 -12,000 -1.06% ✓ $171.4K
Dec 21, 2023 Dec 26, 2023 Enliven Therapeutics, Inc. Chief Scientific Officer Sell 47.5 -6,566 -0.58% ✓ $85.8K
Dec 19, 2023 Dec 21, 2023 Enliven Therapeutics, Inc. Chief Scientific Officer Sell 47.5 -8,888 -0.79% ✓ $115.6K
Nov 3, 2023 Nov 6, 2023 Enliven Therapeutics, Inc. Chief Scientific Officer Sell 47.5 -8,546 -0.76% ✓ $111.8K
Sep 29, 2023 Oct 3, 2023 Enliven Therapeutics, Inc. Chief Scientific Officer Sell 45.0 -12,000 -1.06% ✓ $163.5K